MiR-133a is downregulated in non-small cell lung cancer: a study of clinical significance

BACKGROUND: Despite present studies which suggested miR-133a as a promising biomarker for several cancers, there still exist no articles concerning the validated clinical significance of miR-133a in non-small cell lung cancer (NSCLC). Therefore, in this study, we targeted the correlation between miR...

Descripción completa

Detalles Bibliográficos
Autores principales: Lan, Dong, Zhang, Xin, He, Rongquan, Tang, Ruixue, Li, Ping, He, Qiancheng, Chen, Gang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409717/
https://www.ncbi.nlm.nih.gov/pubmed/25903369
http://dx.doi.org/10.1186/s40001-015-0139-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409717/
https://www.ncbi.nlm.nih.gov/pubmed/25903369
http://dx.doi.org/10.1186/s40001-015-0139-z

Ejemplares similares